Position in JNJ
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$906,164
-$92,617 QoQ
Shares Held
3,568
-12.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.48%
of 13F equity value
Holder Rank
#3,110
of 4,676 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Holos Integrated Wealth LLC holds $1,362,724 across 9 Drug Manufacturers - General names. JNJ ranks #1 (66.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
3,568 | $906,164 | |
| 2 | ABBV |
AbbVie Inc.
|
904 | $227,482 | |
| 3 | MRK |
Merck & Co., Inc.
|
951 | $122,203 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
353 | $44,598 | |
| 5 | AMGN |
Amgen Inc
|
113 | $40,919 | |
| 6 | PFE |
Pfizer Inc
|
672 | $16,181 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
49 | $2,823 | |
| 8 | GSK |
GSK plc
|
32 | $1,677 |
All Filings in JNJ
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $906,164 | 3,568 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $998,781 | 4,086 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $829,041 | 4,006 | Shares | Sole | 2026-01-05 | |
| 2025-09-30 | $742,792 | 4,006 | Shares | Sole | 2026-01-05 | |
| 2025-06-30 | $611,916 | 4,006 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $664,355 | 4,006 | Shares | Sole | 2025-08-08 | |
| 2024-12-31 | $579,347 | 4,006 | Shares | Sole | 2025-08-08 | |
| No filing history on record for this holder in this stock. | ||||||